Effectiveness of a Culturally Adapted Online Education Program (iSupport-Korea) for Family Caregivers of People With Dementia

ConditionDementia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorChungnam National University

About this trial

This randomized controlled trial evaluates the effectiveness of iSupport-Korea, a culturally adapted online education program for family caregivers of people with dementia. A total of 160 caregivers will be randomly assigned to either the intervention or control group and followed for 4 months. The investigators hypothesize that the intervention group will show greater improvements in care-related quality of life, caregiver self-efficacy, and family decision-making self-efficacy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 19 years or older

Family caregivers currently providing care for a person diagnosed with dementia

Informal caregivers such as spouse, children, or relatives

Living with the person with dementia or providing regular care even if not cohabiting

Disqualifiers

Not currently providing direct care to a person with dementia

Participating in another dementia caregiver intervention or similar study

Having severe cognitive impairment, psychiatric illness, or communication difficulties that limit participation

Having severe visual or hearing impairment that interferes with program use

Trial design

Design model

Parallel

Treatments tested in this trial

  • iSupport-Korea

    Behavioral

    iSupport-Korea is a culturally adapted online education and support program for family caregivers of people with dementia. It is designed to enhance caregiver self-efficacy, coping strategies, and overall quality of life through a self-directed learning approach.

  • Dementia information website

    Behavioral

    The control condition consists of access to publicly available dementia-related informational websites.

Treatment groups

160 Participants
are divided into 2 treatment groups
Group A: iSupport-Korea GroupExperimental treatment 1 intervention
Group B: Dementia Information Website GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in subjective well-being (CarerQol-VAS)

Subjective well-being will be measured using the CarerQol-VAS, a visual analogue scale ranging from 0 to 10, with higher scores indicating greater well-being

Time frame
Baseline, 2 months, and 4 months
2

Change in care-related quality of life (CarerQol-7D)

Care-related quality of life will be measured using the Carer-related Quality of Life instrument-7 Dimensions (CarerQol-7D), which assesses caregiving burden across seven dimensions. Each dimension is rated on a 3-level scale (no, some, or a lot of problems), with higher scores indicating better care-related quality of life.

Time frame
Baseline, 2 months, and 4 months

Secondary outcomes

1

Change in caregiver self-efficacy

Caregiver self-efficacy will be measured using a modified version of the Caregiver Self-Efficacy Scale (CSES), consisting of 10 items rated on a 0-10 Likert scale, with higher scores indicating greater caregiver self-efficacy.

Time frame
Baseline, 2 months, and 4 months
2

Change in family decision-making self-efficacy

Family decision-making self-efficacy will be measured using the 13-item Family Decision-Making Self-Efficacy Scale. Items are rated on a 5-point Likert scale ranging from 1 to 5, with higher scores indicating greater confidence in healthcare-related decision-making.

Time frame
Baseline, 2 months, and 4 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.